ProductDescription
LBH589,ahydroxamateanalog,isabroad-spectrumHDACinhibitor.Ithasbeenshowntoincreaseacetylationofcorehistones(H3andH4)andnonhistoneproteins(alpha-tublin,HSP90),leADIngtothemodulationofgeneexpression(p21,FOXO3A,GADD45A,aromatase,etc)andproteinactivityinvolvedincellgrowthandsurvivalpathways1-4.LBH589inducesapoptosisinMOLT-4andRehcellswithIC50between5to20nM1.Inlungcancerandmesotheliomaanimalmodels,LBH589markedlydecreasedtumorgrowthby62%whencomparedwiththevehiclecontrol5.Theanti-tumoractivityofLBH589hasalsobeendemonstratedinmanyothercancercelllines,includingmultiplemyeloma,NSCLCandcastrate-resistantprostatecancercelllines.LBH589isunderclinicaltrialstoevaluateitseffectsinconjunctionwithchemotherapyand/ortargetedtherapyinmultiplecancertypes.
Technicalinformation:
ChemicalFormula: | C21H23N3O2 | |
CAS#: | 404950-80-7 | |
MolecularWeight: | 349.43 | |
Purity: | >98% | |
Appearance: | Whitesolid | |
ChemicalName: | (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide | |
Solubility: | Upto50mMinDMSO |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storage:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
1. | Scuto,A.,etal.Thenovelhistonedeacetylaseinhibitor,LBH589,inducesexpressionofDNAdamageresponsegenesandapoptosisinPh-acutelymphoblasticleukemiacells.Blood.2008May15;111(10):5093-100. |
2. | Chen,S.etal.TheHDACinhibitorLBH589(panobinostat)isaninhibitorymodulatorofaromatasegeneexpression.ProcNatlAcadSciUSA2010Jun15;107(24):11032-7. |
3. | George,P.,etal."CombinationofthehistonedeacetylaseinhibitorLBH589andthehsp90inhibitor17-AAGishighlyactiveagainsthumanCML-BCcellsandAMLcellswithactivatingmutationofFLT-3."Blood105:1768-1776(2005). |
4. | Qian,D.Z.,etal."Targetingtumorangiogenesiswithhistonedeacetylaseinhibitors:thehydroxamicacidderivativeLBH589."Clin.CancerRes.12:634-642(2006). |
5. | Crisanti,MC.etal.TheHDACinhibitorpanobinostat(LBH589)inhibitsmesotheliomaandlungcancercellsinvitroandinvivowithparticularefficacyforsmallcelllungcancer.MolCancerTher.2009Aug;8(8):2221-31. |
Cellagen的ChamQ SYBR qPCR预混液(无ROX)| Q321产品描述ChamQSYBR®qPCR预混液(Vazyme,#Q321)由香槟Taq DNA聚合酶(Vazyme,#P122)通过抗体修饰的热启动激活技术保护,是专为基于SYBR Green I的定量PCR(qPCR)设计的。ChamQSYBR®qPCR Master Mix的优化缓冲液系统中的独特因素(即促进特异性的Exactor)大大提高了其灵敏度和特异性。该混合物以2倍反应浓度制备,可直接用于鲁棒性低模板qPCR,具有高灵敏度,特异性和可靠性。优点特异性+敏感性的最佳组合。独特的抗体修饰的热启动taq,具有独特的特异性促进因子。Mg2 +和染料的最佳浓度。